About Centogene NV (CNTG)

Centogene NV (CNTG), a leading rare disease diagnostics company, provides genetic testing and data solutions to patients, clinicians, and pharmaceutical partners worldwide. The company's mission is to improve the lives of patients with rare diseases by providing fast and accurate diagnosis. With a focus on genetic testing, Centogene offers a wide range of tests that can help identify the underlying cause of a patient's symptoms. These tests include whole genome sequencing, targeted gene panels, and biochemical analysis. Centogene's data solutions allow for easy access to genetic data, facilitating research and drug development. The company's extensive database contains information from over half a million patient samples and is constantly growing.

Centogene NV (CNTG) has been steadily growing its revenue over the past few years, with a compound annual growth rate (CAGR) of around 30%. This growth has been driven by an increase in demand for genetic testing, as well as the company's expansion into new markets. Centogene has a strong network of partnerships with hospitals, research institutions, and pharmaceutical companies, which has helped drive its growth. The company is also actively involved in research and development efforts to bring innovative genetic tests to market. This focus on innovation and collaboration has allowed Centogene to stay at the forefront of the rare disease diagnostics industry.